UBE2M and neoplasm: In addition, tumor sizes measured by caliper were significantly reduced in the mice group bearing UBE2M-depleted HepG2 cells compared to untreated control group by monitoring for 39 days (Figure 7B), which was confirmed by evaluation of isolated tumors from mice (Figure 7C,D).